The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder
Iranian Journal of Child Neurology,
Vol. 9 No. 4 (2015),
8 October 2015
,
Page 48-53
https://doi.org/10.22037/ijcn.v9i4.7375
Abstract
How to Cite This Article: Sharif MR, Madani M, Tabatabaei F, Tabatabaee Z. The Relationship between Serum Vitamin D Levels and
Attention Deficit Hyperactivity Disorder. Iran J Child Neurol. Autumn 2015;9(4): 48-53.
Abstract
Objective
Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent mental health disorders. In recent years, the impacts of various micronutrients on ADHD have been studied. However, vitamin D has received much less attention. This study was aimed at evaluating the association and level of serum vitamin D in children with ADHD.
Materials & Methods
This case-control study was carried out, in 2012, on 6 to 12 yr-old children.
Thirty-seven were children with ADHD in the cases group and another 37 healthy children were in the control group. Venous blood sample was drawn from each child to measure the serum level of vitamin D. Other variables were compared as well.
Results
The mean serum vitamin D level of children with ADHD (19.11±10.10 ng/ml) was significantly lower than that of the control group (28.67±13.76 ng/ml) (P<0.001).
Conclusion
Deficiency of vitamin D has been proved in various psychiatric diseases. This study evidenced a significantly low level of serum vitamin D in children with ADHD. This suggests the need for regularly monitoring of serum vitamin D levels and treatment of patients with vitamin D deficiencies.
- Vitamin D
- Children
- Psychiatric diseases
- ADHD
How to Cite
References
Arnold LE, Hodgkins P, Caci H, Kahle J, Young S. Effect of treatment modality on long-term outcomes in attentiondeficit/ hyperactivity disorder: a systematic review. PLoS One 2015; 25; 10(2):e0116407.
Matthews M, Nigg JT, Fair DA. Attention Deficit Hyperactivity Disorder. Curr Top Behav Neurosci 2014;16: 235– 66.
Gajria K, Lu M, Sikirica V, Greven P, Zhong Y, Qin P, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder –a systematic literature review. Neuropsychiatr Dis Treat 2014; 10: 1543-69.
Leroux JR. Turgay A. Quinn D. Advances in ADHD treatment. Can J Diagn 2009; 26: 49–52.
McGough JJ, Biederman J, Wigal SB, Lopez FA, McCracken JT, Spencer T, et al. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005; 44(6):530-8.
Brooke SG, Molina Stephen P, Hinshaw L, Arnold E, James M, et al. Adolescent Substance Use in the Multimodal Treatment Study of Attention-Deficit/ Hyperactivity Disorder (ADHD) (MTA) as a Function of Childhood ADHD, Random Assignment to Childhood Treatments, and Subsequent Medication. J Am Acad Child Adolesc Psychiatry 2013; 52(3): 250–63.
Ghanizadeh A. Predictors of different types of developmental coordination problems in ADHD: the
effect of age, gender, ADHD symptom severity and comorbidities. Neuropediatrics 2010; 41(4): 176-81.
Halmøy A, Klungsøyr K, Skjærven R, Haavik J. Preand perinatal risk factors in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2012; 71(5): 474-81.
Budziszewska B, Basta-Kaim A, Kubera M, Lasoń W. [Immunological and endocrinological pattern in ADHD etiopathogenesis]. Przegl Lek 2010; 67(11):1200-4.
Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007; 96(9):1269-74.
Millichap JG, Yee MM. The diet factor in attention-deficit/ hyperactivity disorder. Pediatrics 2012 Feb; 129(2): 330-7.
Konikowska K, Regulska-Ilow B, Rózańska D. The influence of components of diet on the symptoms of ADHD in children. Rocz Panstw Zakl Hig 2012;63(2):127-34.
Russell G, Ford T, Rosenberg R, Kelly S. The association of attention deficit hyperactivity disorder with socioeconomic disadvantage: alternative explanations and evidence. J Child Psychol Psychiatry 2014; 55(5):436-45.
Gottfried RJ, Gerring JP, Machell K, Yenokyan G, Riddle MA. The iron status of children and youth in a community mental health clinic is lower than that of a national sample. J Child Adolesc Psychopharmacol 2013; 23(2): 91-100.
Calarge C, Farmer C, DiSilvestro R, Arnold LE. Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2010; 20(6): 495-502.
Cortese S, Angriman M, Lecendreux M, Konofal E. Iron and attention deficit/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature. Expert Rev Neurother 2012; 12(10):1227-40.
Arnold LE, Disilvestro RA, Bozzolo D, Bozzolo H, Crowl L, Fernandez S, et al. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol 2011; 21(1): 1-19.
Lepping P, Huber M. Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder: implications for research and treatment. CNS Drugs 2010; 24(9): 721-8.
Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR. Omega-3 fatty acid status inattention deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2006; 75(4-5): 299-308.
Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 2013; 34(1): 47-64.
Humble MB, Gustafsson S, Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem Mol Biol 2010; 121(1-2): 467-70.
Howland RH. Vitamin D and depression. J Psychosoc Nurs Ment Health Serv 2011; 49(2): 15-8.
Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev 2008; 13(1): 6-20.
Dawodu A, Wagner CL. Mother-child vitamin D deficiency: an international perspective. Arch Dis Child 2007; 92(9): 737-40.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). Washington: The Association 2002.
Heaney RP. Health is better at serum 25(OH)D above 30ng/mL. J Steroid Biochem Mo Biol 2013; 136: 224-228.
Heaney RP. Defining deficiency of vitamin D. Clin Lab Int 2010; 34: 16-19.
Goksugur SB, Tufan AE, Semiz M, Gunes C, Bekdas M, Tosun M, et al. Vitamin D Status in Children with Attention Deficit Hyperactivity Disorder. Pediatr Int 2014; 56(4): 515-9.
Kamal M, Bener A, Ehlayel MS. Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder? Atten Defic Hyperact Disord 2014; 6(2): 73-8.
Rucklidge JJ, Johnstone J, Gorman B, Boggis A, Frampton CM. Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement. Prog Neuropsychopharmacol Biol Psychiatry 2014; 50:163-71.
Tolppanen AM, Sayers A, Fraser WD, Lewis G, Zammit S, Lawlor DA. The association of 25-hydroxyvitamin D3 and D2 with behavioural problems in childhood. PLoS One 2012; 7(7):e40097.
Arns M, van der Heijden KB, Arnold LE, Kenemans JL. Geographic variation in the prevalence of attentiondeficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry 2013; 74(8): 585-90.
Rybak YE, McNeely HE, Mackenzie BE, Jain UR, Levitan RD. An open trial of light therapy in adult
attention-deficit/hyperactivitydisorder. J Clin Psychiatry 2006; 67(10): 1527-35.
Hoebert M, van der Heijden KB, van Geijlswijk IM, Smits MG. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res 2009; 47(1):1-7.
Millichap JG. Etiologic classification of attention-deficit/ hyperactivity disorder. Pediatrics 2008;121(2):e358-65.
Mimouni-Bloch A, Kachevanskaya A, Mimouni FB, Shuper A, Raveh E, Linder N. Breastfeeding may protect from developing attention-deficit/hyperactivity disorder. Breastfeed Med 2013; 8(4):363-7.
Shamberger R. Attention-deficit disorder associated with breast-feeding: a brief report. J Am Coll Nutr 2012; 31(4):239-42.
Bener A, Kamal M. Predict attention deficit hyperactivity disorder? Evidence -based medicine. Glob J Health Sci 2013; 6(2):47-57.
Gow RV, Hibbeln JR. Omega-3 and treatment implications in Attention Deficit Hyperactivity Disorder (ADHD) and associated behavioral symptoms. Lipid Technology 2014;26(1): 7–10.
McCue RE, Charles RA, Orendain GC, Joseph MD, Abanishe JO. Vitamin d deficiency among psychiatric inpatients. Prim Care Companion CNS Disord 2012;14(2).
Menkes DB, Lancaster K, Grant M, Marsh RW, Dean P, du Toit SA. Vitamin D status of psychiatric inpatients in New Zealand’s Waikato region. BMC Psychiatry 2012; 12:68.
Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing “D”ecline. Mol Aspects Med 2008; 29(6):415-22.
Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW.Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65(5):508-12.
Berk M, Dodd S, Kauer-Sant’anna M, Malhi GS, Bourin M, Kapczinski F, et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 2007; (434):41-9.
McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, et al. Neonatal vitamin D status and risk of schizophrenia: A population-based case-control study. Arch Gen Psychiatry 2010; 67(9):889-94.
Mostafa GA, Al-Ayadhi LY. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflammation. 2012 Aug 17;9:201.
Humble MB. Vitamin D, light and mental health. J Photochem Photobiol B 2010; 101(2): 142-9.
Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson- Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009;20(11): 1807-20.
Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson Textbook of Pediatrics. 19th ed. Philadelphia:Elsevier Saunders;2011.
- Abstract Viewed: 736 times